Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Reported sales increased 2.2 percent, which includes the impact from the anticipated decline in COVID-19 testing-related sales versus prior year Organic sales growth for underlying base business of 10.8 percent, which represents the fifth consecutive quarter of double-digit growth ABBOTT PARK , Ill. April 17, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2024 First-quarter GAAP diluted EPS of and adjusted diluted EPS of , which excludes specified items. Abbott narrowed its full-year 2024 EPS guidance range. Abbott projects full-year diluted EPS on a GAAP basis of to and projects adjusted diluted EPS of to , which represents an increase at the midpoint of the range. Abbott narrowed its full-year 2024 organic sales growth guidance range, excluding COVID-19 testing-related sales, to 8.5% to 10.0%, which represents an increase at the midpoint of the range In January, Abbott launched the Protality™ brand, a new
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePR Newswire
- ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]Yahoo! Finance
- Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]Yahoo! Finance
- Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/29/24 - Form 8-K
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- ABT's page on the SEC website